Other safety alerts
|
| |
| Australia: TGA cautions consumers over counterfeit ivermectin |
| |
The Therapeutic Goods Administration (TGA) announces that it has tested a further two imported unregistered medicines and found both to be counterfeit under the Therapeutic Goods Act 1989, containing less ivermectin than claimed. The products, Iverheal-12 and Iverjohn-12, are labelled as containing 12mg of the active pharmaceutical ingredient ivermectin, however laboratory testing has confirmed that they contain less than the declared amount of ivermectin written on the labels.
In Dec 2021, the TGA published a warning about imports of ivermectin. At that time, three products that listed ivermectin on the label were also found to be counterfeit (Iversun-12, Covimectin-12, Ivilife-12).
Consumers are advised to be cautious about ivermectin products that are sold by unverified online stores. Counterfeit and other substandard medicine may be harmful to their health and prevent them from receiving proper medical treatment.
The TGA strongly advises against the practice of self-medicating and self-dosing with ivermectin for the prevention or treatment of COVID-19.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/media-release/tga-cautions-consumers-over-counterfeit-ivermectin
In Hong Kong, the above products are not registered pharmaceutical products. Related news was previously issued by TGA, and was posted on the Drug Office website on 14 Dec 2021.
Ends/Friday, Mar 4, 2022
Issued at HKT 16:00
|
| |
|
